P38 δ MAPK: Emerging Roles of a Neglected Isoform

International Journal of Cell Biology

Volumn 2014, Issue , 2015, Pages

  O'Callaghan, Carol ^a   Fanning, Liam J ^b   Barry, Orla P ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR 2 KINASE; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE 13; STATHMIN; TAU PROTEIN; TUMOR PROMOTER;

APOPTOSIS; CARCINOGENESIS; CELL DIFFERENTIATION; CYTOKINE PRODUCTION; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENZYME ACTIVATION; HUMAN; INFLAMMATORY DISEASE; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; PSORIASIS; REVIEW;

EID: 84923055142     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2014/272689     Document Type: Review

References (110)

1. J. Han, J.-D. Lee, L. Bibbs, and R. J. Ulevitch, "A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells", Science, vol. 265, no. 5173, pp. 808-811, 1994.
2. J. C. Lee, J. T. Laydon, P. C. McDonnell et al., "A protein kinase involved in the regulation of inflammatory cytokine biosynthesis", Nature, vol. 372, no. 6508, pp. 739-746, 1994.
3. J. Rouse, P. Cohen, S. Trigon et al., "A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins", Cell, vol. 78, no. 6, pp. 1027-1037, 1994.
4. N. W. Freshney, L. Rawlinson, F. Guesdon et al., "Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27", Cell, vol. 78, no. 6, pp. 1039-1049, 1994.
5. Y. Jiang, C. Chen, Z. Li et al., "Characterization of the structure and function of a newmitogen-activated protein kinase (p38β)", The Journal of Biological Chemistry, vol. 271, no. 30, pp. 17920-17926, 1996.
6. Z. Li, Y. Jiang, R. J. Ulevitch, and J. Han, "The primary structure of p38γ: a newmember of p38 groupof MAPkinases", Biochemical and Biophysical Research Communications, vol. 228, no. 2, pp. 334-340, 1996.
7. Y. Jiang, H. Gram, M. Zhao et al., "Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinases, p38δ", The Journal of Biological Chemistry, vol. 272, no. 48, pp. 30122-30128, 1997.
8. X. S. Wang, K. Diener, C. L. Manthey et al., "Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase", Journal of Biological Chemistry, vol. 272, no. 38, pp. 23668-23674, 1997.
9. M. Goedert, A. Cuenda, M. Craxton, R. Jakes, and P. Cohen, "Activation of the novel stress-activated protein kinase SAPK4 by cytokines and cellular stresses is mediated by SKK3 (MKK6) ; comparison of its substrate specificity with that of other SAP kinases", The EMBO Journal, vol. 16, no. 12, pp. 3563-3571, 1997.
10. J. L. Brewster, T. de Valoir, N. D. Dwyer, E. Winter, and M. C. Gustin, "An osmosensing signal transduction pathway in yeast", Science, vol. 259, no. 5102, pp. 1760-1763, 1993.
11. M. Li, J. Liu, and C. Zhang, "Evolutionary history of the vertebrate mitogen activated protein kinases family", PLoS ONE, vol. 6, no. 10, Article ID e26999, 2011.
12. A. Cuenda, J. Rouse, Y. N. Doza et al., "SE 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1", FEBS Letters, vol. 364, no. 2, pp. 229-233, 1995.
13. L. Tong, S. Pav, D. M. White et al., "A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket", Nature Structural Biology, vol. 4, no. 4, pp. 311-316, 1997.
14. P. A. Eyers, M. Craxton, N. Morrice, P. Cohen, and M. Goedert, "Conversion of SB 203580-insensitive MAP kinase family members to drug-sensitive forms by a single amino-acid substitution", Chemistry and Biology, vol. 5, no. 6, pp. 321-328, 1998.
15. R. J. Gum, M. M. McLaughlin, S. Kumar et al., "Acquisition of sensitivity of stress-activated protein kinases to the p38 inhibitor, SB 203580, by alteration of one or more amino acids within the ATP binding pocket", The Journal of Biological Chemistry, vol. 273, no. 25, pp. 15605-15610, 1998.
16. Y. Kuma, G. Sabio, J. Bain, N. Shpiro, R. Márquez, and A. Cuenda, "BIRB796 inhibits all p38MAPK isoforms in vitro and in vivo", Journal of Biological Chemistry, vol. 280, no. 20, pp. 19472-19479, 2005.
17. L. R. Coulthard, D. E. White, D. L. Jones, M. F. McDermott, and S. A. Burchill, "p38MAPK: stress responses frommolecular mechanisms to therapeutics", Trends in Molecular Medicine, vol. 15, no. 8, pp. 369-379, 2009.
18. M. C.-T. Hu, Y.-p. Wang, and A. Mikhail, "Murine p38-δ mitogen-activated protein kinase, a developmentally regulated protein kinase that is activated by stress and proinflammatory cytokines", Journal of Biological Chemistry, vol. 274, no. 11, pp. 7095-7102, 1999.
19. G. Sabio, J. S. C. Arthur, Y. Kuma et al., "p38γ regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with GKAP", EMBO Journal, vol. 24, no. 6, pp. 1134-1145, 2005.
20. V. A. Beardmore, H. J. Hinton, C. Eftychi et al., "Generation and characterization of p38β (MAPK11) gene-targeted mice", Molecular and Cellular Biology, vol. 25, no. 23, pp. 10454-10464, 2005.
21. M. Allen, L. Svensson, M. Roach, J. Hambor, J. McNeish, and C. A. Gabel, "Deficiency of the stress kinase p38α results in embryonic lethality: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells", Journal of Experimental Medicine, vol. 191, no. 5, pp. 859-870, 2000.
22. J. Raingeaud, S. Gupta, J. S. Rogers et al., "Pro-inflammatory cytokines and environmental stress cause p38 mitogenactivated protein kinase activation by dual phosphorylation on tyrosine and threonine", Journal of Biological Chemistry, vol. 270, no. 13, pp. 7420-7426, 1995.
23. J. M. Kyriakis and J. Avruch, "Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation", Physiological Reviews, vol. 81, no. 2, pp. 807-869, 2001.
24. P. C. F. Cheung, D. G. Campbell, A. R. Nebreda, and P. Cohen, "Feedback control of the protein kinase TAK1 by SAPK2a/p38α", EMBO Journal, vol. 22, no. 21, pp. 5793-5805, 2003.
25. K. A. Gallo and G. L. Johnson, "Mixed-lineage kinase control of JNK and p38 MAPK pathways", Nature Reviews Molecular Cell Biology, vol. 3, no. 9, pp. 663-672, 2002.
26. H. Ichijo, E. Nishida, K. Irie et al., "Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways", Science, vol. 275, no. 5296, pp. 90-94, 1997.
27. K. Yamaguchi, K. Shirakabe, H. Shibuya et al., "Identification of a member of the MAPKKK family as a potential Mediator of TGF-β signal transduction", Science, vol. 270, no. 5244, pp. 2008-2011, 1995.
28. B. D. Cuevas, A. N. Abell, and G. L. Johnson, "Role of mitogenactivated protein kinase kinase kinases in signal integration", Oncogene, vol. 26, no. 22, pp. 3159-3171, 2007.
29. S. Zhang, J. Han, M. A. Sells et al., "Rho family GT Pases regulate p38 mitogen-activated protein kinase through the downstream mediator Pak1", The Journal of Biological Chemistry, vol. 270, no. 41, pp. 23934-23936, 1995.
30. M. J. Marinissen, M. Chiariello, M. Pallante, and J. S. Gutkind, "A network of mitogen-activated protein kinases links G protein-coupled receptors to the c-jun promoter: a role for c-Jun. NH2-terminal kinase, p38s, and extracellular signal-regulated kinase 5", Molecular and Cellular Biology, vol. 19, no. 6, pp. 4289-4301, 1999.
31. G. Remy, A. M. Risco, F. A. Iñesta-Vaquera et al., "Differential activation of p38MAPK isoforms by MKK6 and MKK3", Cellular Signalling, vol. 22, no. 4, pp. 660-667, 2010.
32. L. Wang, R. Ma, R. A. Flavell, and M. E. Choi, "Requirement of mitogen-activated protein kinase kinase 3 (MKK3) for activation of p38α and p38δ MAPK isoforms by TGF-β1 in murine mesangial cells", The Journal of Biological Chemistry, vol. 277, no. 49, pp. 47257-47262, 2002.
33. J. Schoorlemmer and M. Goldfarb, "Fibroblast growth factor homologous factors and the islet brain-2 scaffold protein regulate activation of a stress-activated protein kinase", Journal of Biological Chemistry, vol. 277, no. 51, pp. 49111-49119, 2002.
34. S. Lawler, Y. Fleming, M. Goedert, and P. Cohen, "Synergistic activation of SAPK1/JNK1 by two MAP kinase kinases in vitro", Current Biology, vol. 8, no. 25, pp. 1387-1391, 1998.
35. C. Tournier, C. Dong, T. K. Turner, S. N. Jones, R. A. Flavell, and R. J. Davis, "MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines", Genes and Development, vol. 15, no. 11, pp. 1419-1426, 2001.
36. T. Wada, K. Nakagawa, T. Watanabe et al., "Impaired synergistic activation of stress-activated protein kinase SAPK/JNK in mouse embryonic stem cells lacking SEK1/MKK4: different contribution of SEK2/MKK7 isoforms to the synergistic activation", Journal of Biological Chemistry, vol. 276, no. 33, pp. 30892-30897, 2001.
37. B. Ge, H. Gram, F. di Padova et al., "MAPKK-independent activation of p38alpha mediated by TAB1-dependent autophosphorylation of p38alpha", Science, vol. 295, no. 5558, pp. 1291-1294, 2002.
38. J. M. Salvador, P. R. Mittelstadt, T. Guszczynski et al., "Alternative p38 activation pathway mediated by T cell receptorproximal tyrosine kinases", Nature Immunology, vol. 6, no. 4, pp. 390-395, 2005.
39. M. Avitzour, R. Diskin, B. Raboy, N. Askari, D. Engelberg, and O. Livnah, "Intrinsically active variants of all human p38 isoforms", FEBS Journal, vol. 274, no. 4, pp. 963-975, 2007.
40. N. Askari, R. Diskin, M. Avitzour, R. Capone, O. Livnah, and D. Engelberg, "Hyperactive variants of p38α induce, whereas hyperactive variants of p38γ suppress, activating protein 1-mediated transcription", Journal of Biological Chemistry, vol. 282, no. 1, pp. 91-99, 2007.
41. X. Zhou, J. D. Ferraris, N. I. Dmitrieva, Y. Liu, and M. B. Burg, "MKP-1 inhibits high Na Cl-induced activation of p38 but does not inhibit the activation of Ton EBP/OREBP: opposite roles of p38α and p38δ", Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5620-5625, 2008.
42. T. Tanoue, T. Yamamoto, R. Maeda, and E. Nishida, "A Novel MAPK phosphatase MKP-7 acts preferentially on JNK/SAPK and p38 alpha and beta MAPKs", The Journal of Biological Chemistry, vol. 276, no. 28, pp. 26629-26639, 2001.
43. C. A. Kraft, T. Efimova, and R. L. Eckert, "Activation of PKCδ and p38δ MAPK during okadaic acid dependent keratinocyte apoptosis", Archives of Dermatological Research, vol. 299, no. 2, pp. 71-83, 2007.
44. A. Cuenda and S. Rousseau, "p38 MAP-Kinases pathway regulation, function and role in human diseases", Biochimica et Biophysica Acta-Molecular Cell Research, vol. 1773, no. 8, pp. 1358-1375, 2007.
45. S. Kumar, P. C. McDonnell, R. J. Gum, A. T. Hand, J. C. Lee, and P. R. Young, "Novel homologues of CSBP/p38MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles", Biochemical and Biophysical Research Communications, vol. 235, no. 3, pp. 533-538, 1997.
46. M. Goedert, M. Hasegawa, R. Jakes, S. Lawler, A. Cuenda, and P. Cohen, "Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases", FEBS Letters, vol. 409, no. 1, pp. 57-62, 1997.
47. G. T. Bramblett, M. Goedert, R. Jakes, S. E. Merrick, J. Q. Trojanowski, and V. M. Y. Lee, "Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding", Neuron, vol. 10, no. 6, pp. 1089-1099, 1993.
48. M. Goedert, "The significance of tau and α-synuclein inclusions in neurodegenerative diseases", Current Opinion in Genetics and Development, vol. 11, no. 3, pp. 343-351, 2001.
49. V. M.-Y. Lee, M. Goedert, and J. Q. Trojanowski, "Neurodegenerative tauopathies", Annual Review of Neuroscience, vol. 24, pp. 1121-1159, 2001.
50. C. G. Parker, J. Hunt, K. Diener et al., "Identification of stathmin as a novel substrate for p38 delta", Biochemical and Biophysical Research Communications, vol. 249, no. 3, pp. 791-796, 1998.
51. L. Jourdain, P. Curmi, A. Sobel, D. Pantaloni, and M.-F. Carlier, "Stathmin: a tubulin-sequestering protein which forms a ternary T2S complexwith twotubulinmolecules", Biochemistry, vol. 36, no. 36, pp. 10817-10821, 1997.
52. P. A. Curmi, S. S. L. Andersen, S. Lachkar et al., "The stathmin/tubulin interaction in vitro", Journal of Biological Chemistry, vol. 272, no. 40, pp. 25029-25036, 1997.
53. A. Knebel, N. Morrice, and P. Cohen, "A novel method to identify protein kinase substrates: eEF2 kinase is phosphorylated and inhibited by SAPK4/p38δ", EMBO Journal, vol. 20, no. 16, pp. 4360-4369, 2001.
54. R. Jørgensen, A. R. Merrill, and G. R. Andersen, "The life and death of translation elongation factor 2", Biochemical Society Transactions, vol. 34, no. 1, pp. 1-6, 2006.
55. B. Gonzalez-Teran, J. R. Cortes, E. Manieri et al., "Eukaryotic elongation factor 2 controls TNF-alpha translation in LPSinduced hepatitis", The Journal of Clinical Investigation, vol. 123, no. 1, pp. 164-178, 2013.
56. T. Efimova, "p38delta mitogen-activated protein kinase regulates skin homeostasis and tumorigenesis", Cell Cycle, vol. 9, no. 3, pp. 498-505, 2010.
57. R. L. Eckert, T. Efimova, S. Balasubramanian, J. F. Crish, F. Bone, and S. Dashti, "p38 mitogen-activated protein kinases on the body surface-a function for p38δ", Journal of Investigative Dermatology, vol. 120, no. 5, pp. 823-828, 2003.
58. S. Balasubramanian, T. Efimova, and R. L. Eckert, "Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes", The Journal of Biological Chemistry, vol. 277, no. 3, pp. 1828-1836, 2002.
59. T. Efimova, A. Deucher, T. Kuroki, M. Ohba, and R. L. Eckert, "Novel protein kinase C isoforms regulate human keratinocyte differentiation by activating a p38δ mitogen-activated protein kinase cascade that targets CCAAT/enhancer-binding protein α", The Journal of Biological Chemistry, vol. 277, no. 35, pp. 31753-31760, 2002.
60. S. R. Dashti, T. Efimova, and R. L. Eckert, "MEK6 regulates human involucrin gene expression via a p38α- and p38δ-dependent mechanism", Journal of Biological Chemistry, vol. 276, no. 29, pp. 27214-27220, 2001.
61. T. Efimova, A.-M. Broome, and R. L. Eckert, "A regulatory role for p38delta MAPK in keratinocyte differentiation: evidence for p38delta-ERK1/2 complex formation", The Journal of Biological Chemistry, vol. 278, no. 36, pp. 34277-34285, 2003.
62. R. Jans, G. Atanasova, M. Jadot, and Y. Poumay, "Cholesterol depletion upregulates involucrin expression in epidermal keratinocytes through activation of p38", Journal of Investigative Dermatology, vol. 123, no. 3, pp. 564-573, 2004.
63. S. R. Dashti, T. Efimova, and R. L. Eckert, "MEK7-dependent activation of p38 MAP kinase in keratinocytes", The Journal of Biological Chemistry, vol. 276, no. 11, pp. 8059-8063, 2001.
64. E. Siljamäki, L. Raiko, M. Toriseva et al., "p38delta mitogenactivated protein kinase regulates the expression of tight junction protein ZO-1 in differentiating human epidermal keratinocytes", Archives of Dermatological Research, vol. 306, no. 2, pp. 131-141, 2014.
65. A. S. Haider, S. B. Peters, H. Kaporis et al., "Genomic analysis defines a cancer-specific gene expression signature for human squamous cell carcinoma and distinguishes malignant hyperproliferation from benign hyperplasia", Journal of Investigative Dermatology, vol. 126, no. 4, pp. 869-881, 2006.
66. C. Johansen, K. Kragballe, M. Westergaard, J. Henningsen, K. Kristiansen, and L. Iversen, "The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin", British Journal of Dermatology, vol. 152, no. 1, pp. 37-42, 2005.
67. S. Uddin, J. Ah-Kang, J. Ulaszek, D. Mahmud, and A. Wickrema, "Differentiation stage-specific activation of p38 mitogenactivated protein kinase isoforms in primary human erythroid cells", Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 1, pp. 147-152, 2004.
68. K. K. Hale, D. Trollinger, M. Rihanek, and C. L. Manthey, "Differential expression and activation of p38 mitogen-activated protein kinase α, β, γ, and δ in inflammatory cell lineages", The Journal of Immunology, vol. 162, no. 7, pp. 4246-4252, 1999.
69. Z. Zhang and J. E. Shively, "Acceleration of bone repair in NOD/SCID mice by human Monoosteophils, novel LL-37-activated monocytes", PLoS ONE, vol. 8, no. 7, Article ID e67649, 2013.
70. A. Gandarillas, "Epidermal differentiation, apoptosis, and senescence: common pathways?" Experimental Gerontology, vol. 35, no. 1, pp. 53-62, 2000.
71. T. Efimova, A.-M. Broome, and R. L. Eckert, "Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex", Molecular and Cellular Biology, vol. 24, no. 18, pp. 8167-8183, 2004.
72. G. Sumara, I. Formentini, S. Collins et al., "Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis", Cell, vol. 136, no. 2, pp. 235-248, 2009.
73. S. A. Price, S. Agthong, A. B. Middlemas, and D. R. Tomlinson, "Mitogen-activated protein kinase p38 mediates reduced nerve conduction in experimental diabetic neuropathy: interactions with aldose reductase", Diabetes, vol. 53, no. 7, pp. 1851-1856, 2004.
74. R. Komers, J. N. Lindsley, T. T. Oyama, D. M. Cohen, and S. Anderson, "Renal p38 MAP kinase activity in experimental diabetes", Laboratory Investigation, vol. 87, no. 6, pp. 548-558, 2007.
75. A. Ittner, H. Block, C. A. Reichel et al., "Regulation of PTEN activity by p38delta-PKD1 signaling in neutrophils confers inflammatory responses in the lung", Journal of Experimental Medicine, vol. 209, no. 12, pp. 2229-2246, 2012.
76. L. B. Ware and M. A. Matthay, "The acute respiratory distress syndrome", New England Journal of Medicine, vol. 342, no. 18, pp. 1334-1349, 2000.
77. F. M. Brennan and I. B. McInnes, "Evidence that cytokines play a role in rheumatoid arthritis", The Journal of Clinical Investigation, vol. 118, no. 11, pp. 3537-3545, 2008.
78. A. Korb, M. Tohidast-Akrad, E. Cetin, R. Axmann, J. Smolen, and G. Schett, "Differential tissue expression and activation of p38 MAPK α, β, γ, and δ isoforms in rheumatoid arthritis", Arthritis and Rheumatism, vol. 54, no. 9, pp. 2745-2756, 2006.
79. G. Criado, A. Risco, D. Alsina-Beauchamp, M. J. Pérez-Lorenzo, A. Escõs, and A. Cuenda, "Alternative p38 MAPKs are essential for collagen-induced arthritis", Arthritis and Rheumatology, vol. 66, no. 5, pp. 1208-1217, 2014.
80. L. M. Kuyper, P. D. Paré, J. C. Hogg et al., "Characterization of airway plugging in fatal asthma", American Journal of Medicine, vol. 115, no. 1, pp. 6-11, 2003.
81. E. Y. Kim, J. T. Battaile, A. C. Patel et al., "Persistent activation of an innateimmune response translates respiratory viral infection into chronic lung disease", Nature Medicine, vol. 14, no. 6, pp. 633-640, 2008.
82. M. Wills-Karp, J. Luyimbazi, X. Xu et al., "Interleukin-13: central mediator of allergic asthma", Science, vol. 282, no. 5397, pp. 2258-2261, 1998.
83. Y. G. Alevy, A. C. Patel, A. G. Romero et al., "IL-13-induced airwaymucus production is attenuated by MAPK13 inhibition", Journal of Clinical Investigation, vol. 122, no. 12, pp. 4555-4568, 2012.
84. I. del Barco Barrantes and A. R. Nebreda, "Roles of p38MAPKs in invasion and metastasis", Biochemical Society Transactions, vol. 40, no. 1, pp. 79-84, 2012.
85. M. R. Junttila, R. Ala-Aho, T. Jokilehto et al., "p38α and p38δ mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells", Oncogene, vol. 26, no. 36, pp. 5267-5279, 2007.
86. S. Rousseau, I. Dolado, V. Beardmore et al., "CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPKMAPKAP-K2-HSP27 pathway", Cellular Signalling, vol. 18, no. 11, pp. 1897-1905, 2006.
87. D. V. Bulavin and A. J. Fornace Jr., "p38 MAP kinase's emerging role as a tumor suppressor", Advances in Cancer Research, vol. 92, pp. 95-118, 2004.
88. J. J. Ventura, S. Tenbaum, E. Perdiguero et al., "p38αMAPkinase is essential in lung stem and progenitor cell proliferation and differentiation", Nature Genetics, vol. 39, no. 6, pp. 750-758, 2007.
89. L. Hui, L. Bakiri, E. Stepniak, and E. F. Wagner, "p38α: a suppressor of cell proliferation and tumorigenesis", Cell Cycle, vol. 6, no. 20, pp. 2429-2433, 2007.
90. F. L.-S. Tan, A. Ooi, D. Huang et al., "p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion", International Journal of Cancer, vol. 126, no. 10, pp. 2353-2361, 2010.
91. M. Egeblad and Z. Werb, "New functions for the matrix metalloproteinases in cancer progression", Nature Reviews Cancer, vol. 2, no. 3, pp. 161-174, 2002.
92. E. M. Schindler, A. Hindes, E. L. Gribben et al., "p38delta Mitogen-activated protein kinase is essential for skin tumor development in mice", Cancer Research, vol. 69, no. 11, pp. 4648-4655, 2009.
93. C. Bourcier, A. Jacquel, J. Hess et al., "p44 mitogen-activated protein kinase (extracellular signal-regulated kinase 1) - dependent signaling contributes to epithelial skin carcinogenesis", Cancer Research, vol. 66, no. 5, pp. 2700-2707, 2006.
94. M. R. Young, J. J. Li, and M. Rincón, "Transgenic mice demonstrate AP-1 (activator protein-1) transactivation is required for tumor promotion", Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 17, pp. 9827-9832, 1999.
95. J. K. Dae, K. S. Chan, S. Sano, and J. Di Giovanni, "Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis", Molecular Carcinogenesis, vol. 46, no. 8, pp. 725-731, 2007.
96. K. S. Chan, S. Sano, K. Kataoka et al., "Forced expression of a constitutively active formof Stat3 inmouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis", Oncogene, vol. 27, no. 8, pp. 1087-1094, 2008.
97. K. S. Chan, S. Sano, K. Kiguchi et al., "Disruptionof Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis", Journal of Clinical Investigation, vol. 114, no. 5, pp. 720-728, 2004.
98. M. I. Cerezo-guisado, P. del Reino, G. Remy et al., "Evidence of p38γ and p38δ involvement in cell transformation processes", Carcinogenesis, vol. 32, no. 7, pp. 1093-1099, 2011.
99. D. Hanahan and R. A. Weinberg, "Hallmarks of cancer: the next generation", Cell, vol. 144, no. 5, pp. 646-674, 2011.
100. C. O'Callaghan, L. J. Fanning, A. Houston, and O. P. Barry, "Loss of p38δ expression promotes oesophageal squamous cell carcinoma proliferation, migration and anchorage-independent growth", International Journal of Oncology, vol. 43, no. 2, pp. 405-415, 2013.
101. C. O'Callaghan, L. J. Fanning, and O. P. Barry, "p38delta MAPK phenotype: an indicator of chemotherapeutic response in oesophageal squamous cell carcinoma", Anti-Cancer Drugs, 2014.
102. Y. K. Choi, S.-M. Woo, S.-G. Cho et al., "Brain-metastatic triplenegative breast cancer cells regain growth ability by altering gene expression patterns", Cancer Genomics and Proteomics, vol. 10, no. 6, pp. 265-275, 2013.
103. Y. Goto, K. Shinjo, Y. Kondo et al., "Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma", Cancer Research, vol. 69, no. 23, pp. 9073-9082, 2009.
104. L. Gao, M. A. Smit, J. J. van den Oord et al., "Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma", Pigment Cell and Melanoma Research, vol. 26, no. 4, pp. 542-554, 2013.
105. Y. Koga, M. Pelizzola, E. Cheng et al., "Genome-wide screen of promoter methylation identifies novel markers in melanoma", Genome Research, vol. 19, no. 8, pp. 1462-1470, 2009.
106. A. Risco and A. Cuenda, "New insights into the p38gamma and p38delta MAPK pathways", Journal of Signal Transduction, vol. 2012, Article ID 520289, 8 pages, 2012.
107. A. Cuadrado and A. R. Nebreda, "Mechanisms and functions of p38 MAPK signalling", Biochemical Journal, vol. 429, no. 3, pp. 403-417, 2010.
108. J. M. Kyriakis and J. Avruch, "Mammalian MAPK signal transduction pathways activated by stress and inflammation: a 10-year update", Physiological Reviews, vol. 92, no. 2, pp. 689-737, 2012.
109. E. Pani and S. Ferrari, "p38MAPKδ controls c-Myb degradation in response to stress", Blood Cells, Molecules, and Diseases, vol. 40, no. 3, pp. 388-394, 2008.
110. W. C. Hawkes and Z. Alkan, "Delayed cell cycle progression in selenoprotein w-depleted cells is regulated by a mitogenactivated protein kinase kinase 4-p38/c-Jun. NH 2-terminal kinase-p53 pathway", Journal of Biological Chemistry, vol. 287, no. 33, pp. 27371-27379, 2012.